Cargando…

Prognostic Relevance of NPM1 and FLT3 Mutations in Acute Myeloid Leukaemia, Longterm Follow-Up—A Single Center Experience

SIMPLE SUMMARY: In acute myeloid leukemia, molecular genetics abnormalities, particularly NPM1 and FLT3 mutations, have a recognized prognostic role in the ELN risk classification and guide treatment decisions, especially since the availability of FLT3-targeted drugs. The NILG-AML 01/00 protocol use...

Descripción completa

Detalles Bibliográficos
Autores principales:	Borlenghi, Erika, Cattaneo, Chiara, Bertoli, Diego, Cerqui, Elisa, Archetti, Silvana, Passi, Angela, Oberti, Margherita, Zollner, Tatiana, Giupponi, Carlotta, Pagani, Chiara, Bianchetti, Nicola, Bottelli, Chiara, Bagnasco, Samuele, Sciumè, Margherita, Tucci, Alessandra, Rossi, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562865/ https://www.ncbi.nlm.nih.gov/pubmed/36230640 http://dx.doi.org/10.3390/cancers14194716

Ejemplares similares

P1538: MULTIDRUG RESISTANT BACTERIAL COLONIZATION AND RELATED BLOODSTREAM INFECTIONS IN FEBRILE HAEMATOLOGIC PATIENTS: EPIDEMIOLOGY AND OUTCOME
por: Cattaneo, Chiara, et al.
Publicado: (2023)

An increase in MYC copy number has a progressive negative prognostic impact in patients with diffuse large B-cell and high-grade lymphoma, who may benefit from intensified treatment regimens
por: Schieppati, Francesca, et al.
Publicado: (2020)

Identification of FLT3 and NPM1 Mutations in Patients with Acute Myeloid Leukaemia
por: Yusoff, Yuslina Mat, et al.
Publicado: (2019)

Postremission sequential monitoring of minimal residual disease by WT1 Q‐PCR and multiparametric flow cytometry assessment predicts relapse and may help to address risk‐adapted therapy in acute myeloid leukemia patients
por: Malagola, Michele, et al.
Publicado: (2015)

Isavuconazole—Animal Data and Clinical Data
por: Pagano, Livio, et al.
Publicado: (2020)

LHCb Longterm Plans
por: Parkes, Chris
Publicado: (2017)

FLT3‐targeted therapy restores GATA1 pathway function in NPM1/FLT3‐ITD mutated acute myeloid leukaemia
por: Sorcini, D, et al.
Publicado: (2023)

GATA1 epigenetic deregulation contributes to the development of AML with NPM1 and FLT3-ITD cooperating mutations
por: Sportoletti, Paolo, et al.
Publicado: (2019)

PB1858: PROGNOSIS AND TREATMENT OF FLT3 MUTATED MYELOID SARCOMA IN THE ERA OF FLT3 INHIBITORS: RETROSPECTIVE EVALUATION IN 5 ITALIAN CENTERS.
por: Lessi, Federica, et al.
Publicado: (2023)

Clinico-Haematologic association and prognostic relevance of NPM1 and FLT3-ITD mutations in acute Myeloid Leukaemia
por: Mahmood, Rafia, et al.
Publicado: (2019)

The beginning of long term longterm
Publicado: (2004)

Longterm endocrine effects of cancer
por: Zacharin, Margaret
Publicado: (2013)

NPM1 and FLT3-ITD/TKD Gene Mutations in Acute Myeloid Leukemia
por: Naseem, Shano, et al.
Publicado: (2021)

Maturation State-Specific Alternative Splicing in FLT3-ITD and NPM1 Mutated AML
por: Wojtuszkiewicz, Anna, et al.
Publicado: (2021)

A case of cup‐like blasts associated with B‐lymphoblastic leukemia without NPM1 and FLT3 internal tandem duplication mutations
por: Rieu, Jean‐Baptiste, et al.
Publicado: (2020)

The value of molecular stratification for CEBPA (DM) and NPM1 (MUT) FLT3 (WT) genotypes in older patients with acute myeloid leukaemia
por: Dickson, Glenda J., et al.
Publicado: (2015)

Mutation of NPM1 and FLT3 Genes in Acute Myeloid Leukemia and Their Association with Clinical and Immunophenotypic Features
por: Chauhan, Pradeep Singh, et al.
Publicado: (2013)

FLT3 and NPM-1 mutations in a cohort of acute promyelocytic leukemia patients from India
por: Swaminathan, Suchitra, et al.
Publicado: (2014)

High Incidence of Invasive Fungal Diseases in Patients with FLT3-Mutated AML Treated with Midostaurin: Results of a Multicenter Observational SEIFEM Study
por: Cattaneo, Chiara, et al.
Publicado: (2022)

PB1762: A NEW MONOCLONAL ANTIBODY PROVIDES INSIGHTS ON NPM1 MUTANT SUBCELLULAR EXPRESSION, INTRACLONAL CELL DIFFERENTIATION AND MRD IN NPM1-MUTATED AML
por: Falini, Brunangelo, et al.
Publicado: (2023)

Seminar on Energy and environment : methods to analyse the longterm relationships
por: Organisation de Coopération et de Développement Economiques. Paris
Publicado: (1974)

Longterm outcome of anal fistula – A retrospective study
por: Andreou, Christos, et al.
Publicado: (2020)

Examination of the FLT3 and NPM1 mutational status in patients with acute myeloid leukemia from southeastern Poland
por: Koczkodaj, Dorota, et al.
Publicado: (2016)

Prognostic impact of NPM1 and FLT3 mutations in patients with AML in first remission treated with oral azacitidine
por: Döhner, Hartmut, et al.
Publicado: (2022)

Molecular characterisation of NPM1 and FLT3-ITD mutations in a central South African adult de novo acute myeloid leukaemia cohort
por: Kloppers, Jean F., et al.
Publicado: (2021)

Screening for hotspot mutations in PI3K, JAK2, FLT3 and NPM1 in patients with myelodysplastic syndromes
por: Machado-Neto, João Agostinho, et al.
Publicado: (2011)

Mutations in AML with a normal karyotype: NPM1 and FLT3-ITD, ready to use as a key prognosticator?
por: Kim, Hee-Je
Publicado: (2010)

Prognostic Relevance of DNMT3A, FLT3 and NPM1 Mutations in Syrian Acute Myeloid Leukemia Patients
por: Moualla, Yahia, et al.
Publicado: (2022)

MiR-424 and miR-155 deregulated expression in cytogenetically normal acute myeloid leukaemia: correlation with NPM1 and FLT3 mutation status
por: Faraoni, Isabella, et al.
Publicado: (2012)

Reproduction and bodyweight of mice after longterm selection for litter size
por: Bakker, H, et al.
Publicado: (1977)

Clinical features of De Novo acute myeloid leukemia with concurrent DNMT3A, FLT3 and NPM1 mutations
por: Loghavi, Sanam, et al.
Publicado: (2014)

The prognostic impact of FLT3-ITD and NPM1 mutations in patients with relapsed acute myeloid leukemia and intermediate-risk cytogenetics
por: How, J, et al.
Publicado: (2013)

High PD-L1 Expression Predicts for Worse Outcome of Leukemia Patients with Concomitant NPM1 and FLT3 Mutations
por: Brodská, Barbora, et al.
Publicado: (2019)

Outcomes of Older Patients with NPM1 Mutated and FLT3-ITD Negative Acute Myeloid Leukemia Receiving Allogeneic Transplantation
por: Jentzsch, Madlen, et al.
Publicado: (2020)

PB1797: THE PROGNOSTIC SIGNIFICANCE OF BCAT1 ON NPM1+FLT3-ITD+ AML PATIENTS AND RELATED MOLECULAR MECHANISMS
por: Pan, Xinan, et al.
Publicado: (2023)

Longterm follow-up in European respiratory health studies – patterns and implications
por: Johannessen, Ane, et al.
Publicado: (2014)

Longterm-habituation of the startle response in mice is stimulus modality, but not context specific
por: Pilz, Peter K. D., et al.
Publicado: (2014)

“Neural Network Responses to Traumatic Stress Predicting its Longterm Consequences”
por: Dirven, B., et al.
Publicado: (2022)

Minor BCR-ABL1-Positive Acute Myeloid Leukemia Associated With the NPM1 Mutation and FLT3 Internal Tandem Duplication
por: Kim, Moon Jung, et al.
Publicado: (2016)

Prognostication refinement in NPM1‐mutated acute myeloid leukemia stratified by FLT3‐ITD status with different induction doses of cytarabine
por: Wang, Biao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_km9lisi85h0cbdpp1rd5d1n8h3